Greenlight Capital Re Ltd SEC Filings

Greenlight Capital Re, Ltd. furnished an update on its recent performance by announcing financial results for the third quarter and nine months ended September 30, 2025. The disclosure was made through a press release attached to an 8‑K.

The company provided its earnings press release as Exhibit 99.1 and an investor presentation dated September 30, 2025 as Exhibit 99.2. Under Item 2.02 and General Instruction B.2, these materials are deemed “furnished” rather than “filed,” are not subject to Section 18 of the Exchange Act, and are not incorporated by reference unless specifically referenced.

Ian Isaacs, a director of Greenlight Capital Re, Ltd. (GLRE), reported a sale of company stock on 09/17/2025. The Form 4 shows the sale of 8,393 ordinary shares at a weighted average price reported as $12.79 (with individual trade prices ranging $12.79 to $12.82). After the reported sale, the filing indicates 71,137 shares beneficially owned directly by the reporting person. The filing also discloses indirect holdings of 25,000 shares held by the Isaacs Living Trust and 25,000 shares held in the Ian Isaacs IRA. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact.

Greenlight Capital Re, Ltd. (GLRE) has filed a Form 144 reporting a proposed sale of 354 common shares through Charles Schwab on 09/17/2025 with an aggregate market value of $4,492.26. The shares were acquired as restricted stock awards on 07/29/2025 and were issued for services rendered. The filing reports 34,198,153 shares outstanding. The notice also discloses sales by Ian Isaacs in the past three months: 2,500 shares on 06/16/2025 for $36,274.15 and 13,000 shares on 06/24/2025 for $193,942.85. Some standard issuer contact fields and the date of the notice are not filled in the submission.

Greenlight Capital Re, Ltd. (GLRE) Form 144 notice reports a proposed sale of 39 shares of common stock through Charles Schwab (3000 Schwab Way, Westlake, TX) with an approximate sale date of 09/15/2025. The filer states the 39 shares were acquired on 07/29/2025 as restricted stock awards from the issuer and the payment was for services rendered. The filing also discloses two recent sales by Ian Isaacs: 2,500 shares sold on 06/16/2025 for $36,274.15 and 13,000 shares sold on 06/24/2025 for $193,942.85. The form includes the issuer's reported number of shares outstanding: 34,198,153 and a standard attestation that the seller is not aware of undisclosed material adverse information.

Greenlight Capital Re, Ltd. (GLRE) notice states an intended sale of 8,000 common shares through Charles Schwab on Nasdaq with an aggregate market value of $100,160 and approximately 34,198,153 shares outstanding. The shares were acquired as restricted stock awards from the issuer on 07/29/2025 and payment was for services rendered. The filer also reported two recent open-market sales by the same person: 2,500 shares on 06/16/2025 for $36,274.15 and 13,000 shares on 06/24/2025 for $193,942.85. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Greenlight Capital Re, Ltd. replaced its term loan with a $50.0 million revolving credit facility that matures on September 3, 2030, and carries interest at Term SOFR plus 3.25% per annum. The company reduced outstanding borrowings under its previous credit agreement from approximately $59.0 million to $50.0 million and used the new Revolving Credit Facility to refinance that balance. The Amended Credit Agreement is guaranteed by substantially all subsidiaries (excluding two regulated insurance subsidiaries) and is secured by a first-priority lien on a collateral account that must maintain a minimum cash balance of $10.0 million held at CIBC.

Separately, Greenlight Reinsurance, Ltd. entered an uncommitted, unsecured £50.0 million letter of credit facility with Citibank Europe plc on September 9, 2025, to support growth of its Funds at Lloyd's business and participation on Lloyd's syndicates. The LC Facility is guaranteed by the parent company and contains customary terms; termination by Citibank includes a specified final expiration provision. Full documents will be filed as exhibits to the company’s Quarterly Report for the quarter ending September 30, 2025.

Greenlight Capital Re, Ltd. (GLRE) Form 4 summary: Thomas James Curnock, Group Chief Underwriting Officer, reported a sale of 11,500 ordinary shares on 08/08/2025 at $12.9345 per share. After this transaction he beneficially owned 179,832 shares directly. The filing was signed by attorney-in-fact Sherry Diaz on 08/12/2025. No derivative securities were reported in Table II.

Greenlight Capital Re, Ltd. (GLRE) reported a Form 4 disclosing that director Murphy Bryan was granted 8,046 ordinary shares as a restricted stock award on 08/07/2025, increasing his reported beneficial ownership to 165,570 shares. The grant was made under the Greenlight Capital Re, Ltd. 2023 Omnibus Incentive Plan.

The restricted shares vest on the earlier of the first anniversary of the grant date and the 2026 annual general meeting of shareholders, meaning the award is time-based and remains subject to forfeiture until vesting. The Form 4 was submitted by a reporting agent on behalf of Mr. Bryan.

Ian Isaacs, a director of Greenlight Capital Re, Ltd. (GLRE), was granted 8,046 ordinary shares as a restricted stock award under the company’s 2023 Omnibus Incentive Plan. The award is set to vest on the earlier of the first anniversary of the grant date and the 2026 annual general meeting of shareholders. The transaction is recorded as an acquisition (Code A) with a transaction date of 08/07/2025. Following the award, the Form 4 shows total beneficial ownership of 79,530 ordinary shares, which includes 25,000 shares held indirectly by the Isaacs Living Trust and 25,000 shares held indirectly by the Ian Isaacs IRA. This disclosure was made on a Form 4 filed under Section 16.